1. The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis 
Joe Datt, Laura Baldock, Emily Pull, Bryn Webber 
Multiple Sclerosis and Related Disorders 
Volume 5, Pages (January 2016)
DOI: /j.msard
Copyright © 2015 The Authors Terms and Conditions

2. Fig. 1
Geographic spread of UK NHS hospital Trusts supported by the RPHC FDO service.
Multiple Sclerosis and Related Disorders 2016 5, 40-46DOI: ( /j.msard )
Copyright © 2015 The Authors Terms and Conditions

3. Fig. 2
FDO monitoring protocol used by RPHC (from Novartis product information).
Multiple Sclerosis and Related Disorders 2016 5, 40-46DOI: ( /j.msard )
Copyright © 2015 The Authors Terms and Conditions

4. Fig. 3 Mean HR (A) and BP (B) at each time point (n=850).
Multiple Sclerosis and Related Disorders 2016 5, 40-46DOI: ( /j.msard )
Copyright © 2015 The Authors Terms and Conditions

5. Fig. 4
Mean change in HR per patient from baseline at each time point (n=850).
Multiple Sclerosis and Related Disorders 2016 5, 40-46DOI: ( /j.msard )
Copyright © 2015 The Authors Terms and Conditions